Mohammadi-Farani, A., Tamasoki, N., & Rahimian, R. (2021). Intra-prefrontal cyclosporine potentiates ketamine-induced fear extinction in rats. Experimental brain research, 239(5), 1401–1415. https://doi.org/10.1007/s00221-021-06050-7
Mohammadi-Farani, A., Limoee, M., & Shirooie, S. (2021). Sodium butyrate enhances fear extinction and rescues hippocampal acetylcholinesterase activity in a rat model of posttraumatic stress disorder. Behavioural pharmacology, 32(5), 413–421. https://doi.org/10.1097/FBP.0000000000000633
Khaledi, E., Noori, T., Mohammadi-Farani, A., Sureda, A., Dehpour, A. R., Yousefi-Manesh, H., Sobarzo-Sanchez, E., & Shirooie, S. (2021). Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice. European journal of pharmacology, 909, 174432. https://doi.org/10.1016/j.ejphar.2021.174432
Mohammadi-Farani, A., Taghadosi, M., Raziee, S., & Samimi, Z. (2021). In vivo blockade of 5HT3 receptors in the infralimbic medial prefrontal cortex enhances fear extinction in a rat model of PTSD. Iranian journal of basic medical sciences, 24(6), 776–786. https://doi.org/10.22038/ijbms.2021.54299.12197
Mohammadi, S., Fakhri, S., Mohammadi-Farani, A., Farzaei, M. H., & Abbaszadeh, F. (2021). Astaxanthin engages the l-arginine/NO/cGMP/KATP channel signaling pathway toward antinociceptive effects. Behavioural pharmacology, 32(8), 607–614. https://doi.org/10.1097/FBP.0000000000000655